跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 25 天前AI 评分29

Aspen, Bambusa 目标 1.35 亿美元 IPO

Aspen, Bambusa target $135M IPOs; AstraZeneca vs. Takeda in gastric cancer ADCs

AI 导读

Aspen Neuroscience 和 Bambusa 均计划进行 1.35 亿美元的 IPO。

正文

Plus news about Hutchmed, John­son & John­son, Jazz Phar­ma­ceu­ti­cals, No­var­tis, Roche and Oru­ka Ther­a­peu­tics.

As­pen, Bam­busa both eye $135M IPOs: As­pen Neu­ro­science

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news